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REGULATION OF CARDIAC PROGENITOR CELLS DURING DEVELOPMENT
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Cardiac progenitor cells of the second heart À eld (SHF) contribute to the poles of the elongating embryonic heart. Failure or perturbation of SHF development leads to congenital heart defects. Recent studies have demonstrated the existence, in the postnatal heart, of resident cardiac progenitor cells that speciÀ cally express the transcription factor Islet1, a SHF marker, and that have the potential to differentiate into cardiomyocytes, smooth muscle and endothelial cells. Interestingly, several evidences suggest that these residual progenitor cells arise from the SHF.
Through analysis of a transgene integration site position effect we have identiÀ ed the transcriptional repressor Hes1 as a novel regulator of SHF development. Hes1, a target gene of the Notch signaling pathway, is expressed SHF progenitor cells. Analysis of E15.5 Hes1-/-embryos reveals outÁ ow tract alignment defects (ventricular septal defects and overriding aorta). At earlier developmental stages, Hes1-/-embryos display SHF proliferation defects, cardiac neural crest cells reduction and fail to completely extend the outÁ ow tract. Thus these data reveal a role for Hes1, and potentially Notch signaling, in SHF development.
Given the importance of Isl1 as a marker of resident progenitor cells in the later heart we are analysing the role of known and novel regulators of the SHF (Hes1, Fgf10 and Tbx1) in the regulation of myocardial progenitor cell fate and in the deÀ nition of the critical niche occupied by residual cardiac progenitor cells in the forming and deÀ nitive heart. In Fgf10-/-mice, outÁ ow tract alignment occurs normally. However, Fgf10-/-hearts are highly dysmorphic. We thus hypothesize that Fgf10 deletion may affect the proliferative capacities of SHF progenitors in order to maintain the residual progenitor cells pool in the fetal heart. Initial results have revealed that whereas Fgf10-/-hearts undergo heart tube extension normally, proliferation is impaired.
Together, our results identify Hes1 as a novel regulator of SHF progenitor cell deployment and reveal a potential role of Fgf10 in regulating cardiac progenitor cell fate and cardiac growth during the fetal period. This study will increase our understanding of the molecular mechanisms governing the maintenance and differentiation of cardiac progenitor cells. Notch3 code pour un récepteur transmembranaire dont l'expression est fortement restreinte aux cellules musculaires lisses (CML) des petites artères. Des études génétiques chez l'homme et la souris ont démontré que Notch3 était un acteur clé dans la physiologie normale et la pathologie des petites artères. Chez l'homme, des mutations dominantes de Notch3 sont responsables de la maladie CADASIL, une forme héréditaire de maladie des petites artères cérébrales. Chez la souris, Notch3 est requis pour la maturation postnatale des petites artères, en contrôlant l'identité artérielle et le remodelage du cytosquelette des CML. Notch3 joue également un rôle clé dans la fonction normale des petites artères, en contrôlant les réponses myogéniques à la pression artérielle. L'activation de Notch3, dans la voie canonique, induit, par clivage protéolytique, la libération de son domaine intracellulaire qui se lie dans le noyau à RBP-Jk, favorisant la formation d'un complexe activateur de la transcription. We previously reported that deletion of estrogen receptor-alpha (ER-alpha) abolishes endothelial response to wine polyphenols. The present study was designed to demonstrate that delphinidin, an anthocyanin that possess the same pharmacological proÀ le than wine polyphenols in vascular protection, mediates its action via direct activation of ER-alpha receptor. Both 17-beta estradiol and the speciÀ c ER-alpha agonist, propyl pyrazole triol (PPT), induced endothelium-dependent relaxation in aorta from ovariectomized female ER-alpha wild type but not in ER-alpha knock out mice. In the following experiments, 17-beta estradiol, PPT and delphinidin were used at maximally active concentrations at which they produced endothelium-dependent relaxation. ER-apha deletion abrogated the endothelial relaxation to delphinidin. In human endothelial cell line, Eahy 926, both 17-beta estradiol (10 õm) and PPT (10 õm) were able to increase nitric oxide (NO) production evaluated by electron paramagnetic resonance. Interestingly, the speciÀ c ER-alpha antagonist, fulvestrant (30 nM), did not affect basal NO level but it completely prevented the response to 17-beta estradiol and PPT. Besides, the capacity of delphinidin (10 õg/ml) in increasing NO production was blunted when ER-alpha was inhibited either pharmacologically with fulvestrant or after depletion of ER-alpha receptor with siRNA. Western blot analysis showed that 17-beta estradiol, PPT and delphinidin increased interaction between ER-alpha, caveolin-1 (Cav-1) and c-Src, and enhanced phosphorylation of Cav-1, c-Src, P42/44 MAPkinase and endothelial NO synthase (eNOS) in endothelial cells. Antagonizing ER-alpha with fulvestrant or depletion of endogenous ER-alpha with siRNA completely abolished 17-beta estradiol-, PPT-and delphinidininduced phosphorylation of Cav-1, c-Src, P42/44 MAPkinase and eNOS. Finally, delphinidin induced 73 % inhibition of speciÀ c binding of ER-alpha agonist Á uoligand using in vitro human ER-alpha receptor binding assay. Altogether, we provide direct evidence that delphinidin activates ER-alpha receptor and stimulates the interaction of this receptor with Cav-1, c-Src, P42/44 MAPkinase and eNOS to induce NO production in endothelial cells. Thus, ERalpha activation is probably involved in the therapeutic beneÀ t of delphinidin in cardiovascular diseases associated with endothelial dysfunction.
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ROLE DU COMPLEXE PROTEIQUE ERM DANS LA TRANSMISSION DES EFFETS DE L'ACTIVATION DE L'ECHANGEUR NHE1 EN REPONSE A L'ACIDIFICATION DES MYOCYTES CARDIAQUES
A. DARMELLAH-REMIL 1 , C. RUCKER-MARTIN 1 , D. FEUVRAY 1 1 Université Paris-Sud 11 & CNRS UMR 8162, Le Plessis-Robinson, France
Nous avons étudié le rôle du complexe protéique ezrine/radixine/ moésine (ou complexe ERM, relié au cytosquelette) dans la transmission du signal donné par l'augmentation d'activité de l'échangeur Na+/H+, NHE1, en réponse à une acidiÀ cation intracellulaire. L'étude a été réalisée sur myocytes ventriculaires gauches isolés de coeurs de rats adultes (rats Wistar témoins et rats diabétiques GK). La détection des protéines ERM actives (i.e. phosphorylées) par immuno-marquage a permis de révéler que, dans les conditions basales et en dehors de toute stimulation, ces protéines sont localisées au niveau des disques intercalaires, aussi bien dans les myocytes de rats témoins que de rats GK. L'acidiÀ cation entraîne une augmentation signiÀ cative de la phosphorylation des protéines ERM avec remodelage intracellulaire de ces protéines ; elles sont alors localisées à proximité des récepteurs de la ryanodine, vraisemblablement au niveau des tubules-T. Ces observations ont été faites aussi bien dans les cardiomyocytes ventriculaires de rats témoins que de rats diabétiques GK, avec un remodelage plus marqué chez ces derniers. Un autre résultat d'importance est l'observation d'une augmentation d'activité de Akt, parallèle à celle du complexe ERM : augmentation avec l'acidiÀ cation et absence d'augmentation lorsque l'acidiÀ cation a été induite en présence d'un inhibiteur de NHE1. De plus, l'exploration de deux voies cibles de Akt, la voie mTOR/p70S6K et la voie GSK-3b, a montré que seule la phosphorylation de la GSK-3b est augmentée lors d'une stimulation marquée de l'activité de la voie NHE1/ERM/ Akt. L'ensemble de ce travail, nous a permis de mettre en évidence qu'une activité élevée de l'échangeur NHE1 constitue un signal capable d'enclencher, via le complexe protéique ERM, une cascade d'événements intracellulaires pouvant notamment aboutir, comme montré précédemment¹, à une réponse hypertrophique. Ceci nous semble être un résultat fondamental qui met en lumière un rôle important de NHE1, lorsque celui-ci est sollicité de façon excessive (par exemple au cours d'une ischémie chronique), à côté de son rôle reconnu de mécanisme majeur de régulation du pH interne des cellules.
¹Darmellah A et al. Diabetologia 2007 ; 50 : 1335 -1344 To deÀ ne the vascular role of aldosterone and the mineralocorticoid receptor (MR) in cardiovascular pathophysiology, we generated a conditional transgenic mouse model that allows a spatio-temporal control of MR expression in vivo. To speciÀ cally assess the role of MR in the vessels, MR over-expression has been achieved in endothelial cells, using the tetracycline conditional system and an endothelium-speciÀ c promoter (VE-Cadherin).
We previously described increase sensitivity to vasoconstrictors (phenylephrine, endothelin-1, thromboxane-A2, angiotensin II) in mesenteric arteries such as in aorta of mice over-expressing the MR in the endothelium (MR-EC) in presence of a normal relaxation to vasodilatators (acetylcholine, bradykinin, nitroprusside). In vivo, blood pressure (BP) was increased in awaked MR-EC mice, as compared to the controls (CT) (tail-cuff method).
We have investigated, using pharmacological antagonists, the role of the small (SKCa), and the intermediate (IKCa) and the big (BKCa) conductance potassium channels in vascular function. In infra-renal aorta, endothelial SKCa and IKCa channel blockade (Apamin 1 õm + TRAM-34 1 õm) unmasked an impaired relaxation to acetylcholine in MR-EC mice as compared to controls. Inhibition of the smooth muscle speciÀ c BKCa channel with Iberiotoxin (0.1 õm) blunted the higher phenylephrin-induced contractile response observed in MR-EC as compared to CT. Taken together, these pharmacological data suggest that endothelial MR overexpression is associated with an increased activity of EDHF-mediating endothelial Ca-activated K channels and a functional decrease of the smooth-muscle BKCa channel activity. Western-blot analyses when then performed to analyze the protein expression levels of the various channel subunits of the endothelial SK3 and IK and smooth-muscle BK
